Medtronic PLC closed $1.63 below its 52-week high ($91.49), which the company achieved on September 4th.

While it may not be enough for some shareholders, we think it is good to see the Medtronic plc ( NYSE:MDT ) share ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

"It’s imperative that we use every tool at our disposal," Goodheart said of worrying cardiovascular death trends for women.

As transformational as the pacemaker was, Martha believes a new Medtronic procedure, just approved by the FDA, will be even ...

Earnings announcement expected in 57 days. 20-year pro options trader reveals his one-line chart technique that shows when to ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.